Vifor Pharma AG

Vifor Pharma AG VIFN

Dividend Summary


The previous Vifor Pharma AG dividend was 200c and it went ex almost 2 years ago and it was paid almost 2 years ago.
There is typically 1 dividend per year (excluding specials).

Latest Dividends
Summary Previous dividend Next dividend
Status Paid
Type Final
Per share 200c
Declaration date
Ex-div date 29 Apr 2022 (Fri)
Pay date 03 May 2022 (Tue)

Enter the number of Vifor Pharma AG shares you hold and we'll calculate your dividend payments:

Previous Payment
Next Payment
Forecast Accuracy
99%
Our premium tools have predicted Vifor Pharma AG with 99% accuracy.
Dividend Yield Today
0.0%
The dividend yield is calculated by dividing the annual dividend payment by the prevailing share price
The table below shows the full dividend history for Vifor Pharma AG
Status Type Decl. date Ex-div date Pay date Decl. Currency Forecast amount Decl. amount Accuracy
Paid Final 29 Apr 2022 03 May 2022 CHF 200c 200c 😄
Paid Final 03 Mar 2021 10 May 2021 12 May 2021 CHF 200c 200c 😄
Paid Final 12 Mar 2020 18 May 2020 20 May 2020 CHF 200c 200c 😄
Paid Final 14 Mar 2019 10 May 2019 14 May 2019 CHF 200c
Paid Final 15 Mar 2018 17 May 2018 22 May 2018 CHF 200c
Paid Final 14 Mar 2017 16 May 2017 18 May 2017 CHF 2000c
Paid Final 03 May 2016 06 May 2016 CHF 1800c
Paid Final 12 May 2015 15 May 2015 CHF 1500c
Paid Final 13 May 2014 16 May 2014 CHF 1400c
Paid Final 06 May 2013 10 May 2013 CHF 1100c
Year Amount Change
2006 0.0c
2007 0.0c
0%
2008 0.0c
0%
2009 0.0c
0%
2010 0.0c
0%
2011 0.0c
0%
2012 1100.0c
100%
2013 1400.0c
27.3%
2014 1500.0c
7.1%
2015 1800.0c
20.0%
2016 2000.0c
11.1%
2017 200.0c
-90.0%
2018 200.0c
0%
2019 200.0c
0%
2020 200.0c
0%
2021 200.0c
0%

Vifor Pharma AG Optimized Dividend Chart

The chart below shows the optimized dividends for this security over a rolling 12-month period.
Dividend Yield Today
0.0%
Optimized Yield
Sign Up Required
52 Week High
0.0% on 21 April 2023
52 Week Low
0.0% on 21 April 2023
Next Ex-Div-Date Countdown
Sign Up Required

About Vifor Pharma AG

Vifor Pharma AG, formerly known as Galenica AG, is a Switzerland-based company engaged in the healthcare market. The Company operates through a single pharmaceutical segment. It develops, manufactures and markets pharmaceutical products, specializing in therapies for iron deficiency, nephrology and cardio-renal diseases. The Company's portfolio of iron deficiency treatments includes intravenous products, Ferinject and Venofer, and oral product, Maltofer, among others. Its portfolio of renal pharmaceuticals includes products for anaemia management, such as Mircera, mineral and bone management, such as Velphoro, Rayaldee and Osvaren, and cardio-renal management, such as patiromer (in the United States sold under the brand Veltassa). The Company also conducts research in the area of infectious and rare diseases, partnering with other biopharmaceutical companies. The Company has production sites in Switzerland and Portugal as well as a network of affiliates and partners around the world.

Sector
Health Care Equipment & Services
Country
Switzerland
Share Price
Fr.166.15 (closing price on 18 Apr 2024)
Shares in Issue
65 million
Market Cap
Fr.10.8bn
CADI
The Consecutive Annual Dividend Increases - the number of years this company has been increasing its dividends
0
Market Indices
STOXX600
No articles found